EXACT SCIENCES Earnings Preview: Recent Insider Trading and Hedge Fund Activity on $EXAS

EXACT SCIENCES is set to report its quarterly earnings data after the markets close on November 3rd, with analysts predicting revenue of $826,381,407 and earnings of -$0.07 per share, according to Finnhub. Those interested can find detailed information on insider trading, hedge fund activity, and congressional trading regarding EXACT SCIENCES stock on Quiver Quantitative’s dedicated page.

Insider trading activity for EXACT SCIENCES shows that insiders have executed 5 trades on the open market over the last 6 months, with all being sales and none purchases. Among these transactions, KATHERINE S ZANOTTI conducted 2 sales of 15,207 shares totaling approximately $950,612, while JAMES EDWARD DOYLE made 2 sales amounting to 3,485 shares with an estimated value of $182,399. Additionally, JAMES HERRIOTT, the Senior Vice President, General Counsel and Secretary, sold 1,500 shares for an estimated $90,000.

When it comes to hedge fund activity, 260 institutional investors have increased their holdings of EXACT SCIENCES stock, while 281 have decreased their positions in the most recent quarter. Notable movements in portfolio holdings include PRICE T ROWE ASSOCIATES INC /MD/ removing 2,700,607 shares (42.2%) from their portfolio in the second quarter of 2025, valued at around $143,510,255. On the other hand, GOLDMAN SACHS GROUP INC added 1,486,137 shares (204.1%) to their holdings in the same quarter, totaling approximately $78,973,320.

Within the past year, EXACT SCIENCES has received $592,152 in award payments for various contracts. Noteworthy payments include $323,800 for testing services for patient care, $124,588 for Oncotype cancer testing, and $114,305 for genetic testing services.

Wall Street analysts have issued favorable reports on EXACT SCIENCES in recent months, with 5 firms giving buy ratings and none issuing sell ratings. Noteworthy ratings include a “Buy” from BTIG on October 22, 2025, and an “Overweight” from Piper Sandler on October 8, 2025, among others.

Multiple analysts have assigned price targets for EXACT SCIENCES, with a median target of $68.0. Recent price targets from various analysts range from $46.0 to $85.0. This information is vital for investors interested in tracking analyst ratings and price targets for EXACT SCIENCES stock.

It is essential to note that this article does not provide financial advice and that exact details may vary due to inaccuracies in ticker-mapping and other anomalies. For those looking for detailed information, Quiver Quantitative provides comprehensive analysis, insight, and data on EXACT SCIENCES and other publicly traded stocks.